For instance, the BCR-ABL fusion transcript is a defining marker for chronic myeloid leukemia (CML) [13], while EML4-ALK fusions are found in a subset of non-small-cell lung cancers [14]. Here, EML4 is linked to non-small cell lung carcinoma.